Literature DB >> 7529623

Vaginal clear cell carcinoma in a young patient with ectopic termination of the left ureter in the vagina.

M M Ott1, M Rehn, J G Müller, A Gruss, J Martius, T Steck, H K Müller-Hermelink.   

Abstract

The association of clear cell adenocarcinoma of the vagina and vaginal adenosis with prenatal exposure to diethylstilbestrol (DES) is well-documented in the United States. In Europe, however, DES was never used in the therapy of threatened abortion and, therefore, clear cell adenocarcinoma and vaginal adenosis remained rare diseases. We report on the clinical and pathological features of a case of clear cell adenocarcinoma of the upper vagina in a 17-year-old German girl, who had a history of hypoplasia of the left kidney with an ectopic termination of the ureter in the upper vagina, removed surgically 2 years before. No previous report of a similar coincidence of vaginal clear cell carcinoma and a congenital disorder of the genitourinary tract exists. Congenital anomaly of the ureter interfering with the development and the differentiation of the distal Müllerian tract and its epithelium might have provided a similar histological basis for carcinogenesis in our patient to that in those provided exposed to DES.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529623     DOI: 10.1007/bf00189584

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  Colonic neoplasms complicating ureterosigmoidostomy.

Authors:  A Lasser; A E Acosta
Journal:  Cancer       Date:  1975-04       Impact factor: 6.860

2.  The incidence and histogenesis of vaginal adenosis. An autopsy study.

Authors:  R J Kurman; R E Scully
Journal:  Hum Pathol       Date:  1974-05       Impact factor: 3.466

3.  Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women.

Authors:  A L Herbst; H Ulfelder; D C Poskanzer
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

4.  A hypothetic mechanism of diethylstilbestrol(DES)-induced anomalies in exposed progeny.

Authors:  S J Robboy
Journal:  Hum Pathol       Date:  1983-10       Impact factor: 3.466

5.  Carcinoma at the site of ureterosigmoidostomy.

Authors:  C A Sheldon; C R McKinley; P R Hartig; R Gonzalez
Journal:  Dis Colon Rectum       Date:  1983-01       Impact factor: 4.585

Review 6.  Current status of tumor of the bowel following ureterosigmoidostomy: a review.

Authors:  D A Husmann; H M Spence
Journal:  J Urol       Date:  1990-09       Impact factor: 7.450

Review 7.  Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature.

Authors:  R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1985-11       Impact factor: 6.394

8.  Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.

Authors:  S Melnick; P Cole; D Anderson; A Herbst
Journal:  N Engl J Med       Date:  1987-02-26       Impact factor: 91.245

9.  [Adenocarcinoma and adenosis of the vagina. On the histogenesis, diagnosis and therapy of a rare genital neoplasms].

Authors:  V Maassen; B Lampe; M Untch; S Mikorey; H Hepp; G Kindermann
Journal:  Geburtshilfe Frauenheilkd       Date:  1993-05       Impact factor: 2.915

10.  Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.

Authors:  A L Herbst; P Cole; T Colton; S J Robboy; R E Scully
Journal:  Am J Obstet Gynecol       Date:  1977-05-01       Impact factor: 8.661

View more
  2 in total

Review 1.  A tumor of an ectopic ureter mimicking uterine cervix adenocarcinoma: case report and brief review.

Authors:  Mehdi Jaidane; Adel Slama; Mohammed Bibi
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-04-29

Review 2.  Malignant transformation of vaginal adenosis to clear cell carcinoma without prenatal diethylstilbestrol exposure: a case report and literature review.

Authors:  Lihong Pang; Lei Li; Lan Zhu; Jinghe Lang; Yalan Bi
Journal:  BMC Cancer       Date:  2019-08-13       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.